|1.||Ortiz, Mario I: 3 articles (12/2010 - 01/2010)|
|2.||Kaba, H: 3 articles (01/2003 - 12/2000)|
|3.||Okutani, F: 3 articles (01/2003 - 12/2000)|
|4.||Inoue, S: 3 articles (01/2003 - 12/2000)|
|5.||Kapur, Arvinder: 2 articles (08/2015 - 01/2012)|
|6.||Patankar, Manish S: 2 articles (08/2015 - 01/2012)|
|7.||Hua, Kuo-Feng: 2 articles (01/2015 - 01/2013)|
|8.||Ka, Shuk-Man: 2 articles (01/2015 - 01/2013)|
|9.||Ho, Chen-Lung: 2 articles (01/2015 - 01/2013)|
|10.||Chen, Ann: 2 articles (01/2015 - 01/2013)|
05/01/2005 - "In this study, we investigated the anti-cancer potential of citral and its mode of action. "
01/01/1991 - "When the study was terminated at 20 weeks of promotion all mice had at least one tumor, but the number of tumors per affected mouse were lower in the citral treated groups. "
08/01/2015 - "Geranial at 80 mg/kg was most effective at inhibiting tumor growth. "
02/01/2003 - "No neoplasms were attributed to citral in rats or mice. "
01/01/2003 - "No neoplasms or nonneoplastic lesions were attributed to exposure to citral. "
|2.||Endometrial Neoplasms (Endometrial Cancer)
|3.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
07/01/1994 - "Our group has developed an experimental model for the study of rat prostatic hyperplasia and/or dysplasia induced by citral--a flavor constituent. "
01/01/2010 - "Citral induced mild benign prostatic hyperplasia. "
01/01/1992 - "Estrogenic action of commonly used fragrant agent citral induces prostatic hyperplasia."
01/01/1986 - "Typical lesions of benign prostatic hyperplasia (BPH) were induced experimentally in the ventral prostate of adolescent (6 week old) male rats by citral, a nonsteroidal compound. "
02/01/2001 - "One of these factors is citral, a widely-used cosmetic fragrance constituent, which causes severe prostatic hyperplasia in rats. "
|4.||Breast Neoplasms (Breast Cancer)
08/01/2015 - "Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model."
09/01/2015 - "The results of this study suggest that curcumin and citral in combination may be a useful therapeutic intervention for breast cancer."
10/01/2009 - "In this study, we investigated the effect of citral (3,7-dimethyl-2,6-octadienal), a key component of essential oils extracted from several herbal plants, on the proliferation rate, cell cycle distribution, and apoptosis of the human breast cancer cell line MCF-7. "
09/01/2015 - "With combination curcumin and citral treatment, apoptosis induction and cell cycle arrest at G0/G1 phase in breast cancer cells were observed. "
09/01/2015 - "Curcumin and citral caused dose and time dependent cell death and showed a synergistic effect at effective concentration EC50 and above concentrations in breast cancer cells without disturbing normal breast epithelial cells. "
10/01/2008 - "The identification of this induction threshold will allow for risk assessments to focus on primary prevention of contact allergy to citral based on a new Quantitative Risk Assessment (QRA) paradigm. "
08/01/2007 - "Chelitis from contact allergy to citral in lip salve."
01/01/1984 - "As could be expected, contact allergy to turpentine oil was confirmed in the first case, whereas the actual eczematogenic in the second case, in which turpentine oil was negative, may have been citral."
01/01/1983 - "The possible role of limonene in alleviating the allergic reaction to citral is discussed."
08/01/1989 - "Although most reported cases of citrus peel allergy are due to d-limonene, for our patient, reactions to patch tests for geraniol and citral, two minor components of citrus peel oil, were positive, whereas those for d-limonene were negative. "
|3.||Vitamin A (Retinol)
|5.||Tretinoin (Retinoic Acid)
|10.||Volatile Oils (Essential Oils)
|1.||Drug Therapy (Chemotherapy)
|2.||Heterologous Transplantation (Xenotransplantation)